Cencora/$COR
1D1W1MYTD1Y5YMAX
Capital at risk
About Cencora
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
- Ticker
- $COR
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 49,000
- Headquarters
- Conshohocken, United States
- Website
- www.cencora.com
Cencora Metrics
BasicAdvanced
$59B
22.80
$13.46
0.57
$2.40
0.78%
Price and volume
Market cap
$59B
Beta
0.57
52-week high
$377.54
52-week low
$244.82
Average daily volume
1.2M
Dividend rate
$2.40
Financial strength
Current ratio
0.935
Quick ratio
0.477
Long term debt to equity
3.533
Total debt to equity
3.619
Dividend payout ratio (TTM)
17.83%
Interest coverage (TTM)
8.78%
Profitability
EBITDA (TTM)
5,546.476
Gross margin (TTM)
3.96%
Net profit margin (TTM)
0.79%
Operating margin (TTM)
1.35%
Effective tax rate (TTM)
26.82%
Revenue per employee (TTM)
$6,790,000
Management effectiveness
Return on assets (TTM)
3.56%
Return on equity (TTM)
96.87%
Valuation
Price to earnings (TTM)
22.8
Price to revenue (TTM)
0.179
Price to book
18.08
Price to tangible book (TTM)
-3.05
Price to free cash flow (TTM)
14.662
Free cash flow yield (TTM)
6.82%
Free cash flow per share (TTM)
20.933
Dividend yield (TTM)
0.78%
Forward dividend yield
0.78%
Growth
Revenue change (TTM)
5.09%
Earnings per share change (TTM)
39.11%
3-year revenue growth (CAGR)
9.36%
10-year revenue growth (CAGR)
8.68%
3-year earnings per share growth (CAGR)
18.02%
10-year earnings per share growth (CAGR)
6.18%
3-year dividend per share growth (CAGR)
7.06%
10-year dividend per share growth (CAGR)
6.02%
What the Analysts think about Cencora
Analyst ratings (Buy, Hold, Sell) for Cencora stock.
Analyst projections of the future price of Cencora stock.
Bulls say / Bears say
International operations are providing a second growth engine. Third-quarter international operating income rose 20.8%, driven by European distribution and specialty logistics, while full-year international operating-income growth is expected to be about 9%. (Morningstar, BioSpace)
Cencora is returning excess cash while continuing to invest in growth. It repurchased $1 billion of shares in the quarter and still expects about $3 billion of adjusted free cash flow for fiscal 2026, which can support per-share earnings and shareholder returns. (BioSpace, Investing.com)
Core US distribution remains exposed to pricing and customer pressure. Third-quarter growth was partly offset by manufacturer list-price reductions worth a $2.4 billion revenue headwind, the loss of an oncology customer and lower sales to a large mail-order customer. (BioSpace, Yahoo Finance)
Acquisition-led growth is carrying a higher financing burden. Net interest expense rose 72% year on year to $140.7 million in the third quarter, while full-year interest expense is expected to be about $490 million versus $292 million in fiscal 2025. (Yahoo Finance, TradingKey)
The planned MWI Animal Health merger with Covetrus could reduce near-term earnings from the Other segment. Management said a mid-year completion could create a $150 million operating-income headwind, or roughly $0.35 of EPS after the transaction structure is considered. (The Motley Fool)
Data summarised monthly by Lightyear AI. Last updated on 16 Sept 2026.
Cencora Financial Performance
Revenues and expenses
Cencora Earnings Performance
Company profitability
Upcoming events
No upcoming events
Cencora News
AllArticlesVideos
Funds containing Cencora
AllEURUSDGBP
Fund name | Fund size | $COR weighting |
|---|---|---|
iShares MSCI World Health Care Sector Advanced€CBUF | €606M | 1.67% |
iShares Edge MSCI World Minimum Volatility$MVOL | $2.6B | 1.06% |
iShares Edge MSCI World Minimum Volatility€IQQ0 | €2.3B | 1.06% |
iShares Edge MSCI World Minimum Volatility£MINV | £1.9B | 1.06% |
iShares S&P 500 Health Care Sector€IUHE | €125M | 0.96% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.